NET INCOME (LOSS) PER SHARE (Tables)

12 Months Ended

Dec. 31, 2023

Schedule of Basic and Diluted Net (Income) Loss Per Common Share

The following table sets forth the net income (loss) and the computation of basic and diluted net income (loss) per common share for the periods indicated. Share and per-share amounts below have been restated to reflect the 1-for-100 Reverse Stock Split that the Company completed on November 3, 2023, as discussed in Note 1, "Nature of Business and Operations".


	Years Ended December 31,
(in thousands, except shares and per share data)		2023		2022		2021
Numerator:
Net income (loss)		$	(1,098,903)	$	(428,389)	$	(116,737)
Less: net income (loss) attributable to non-controlling interests		(504,485)		(221,117)		(98,717)
Net income (loss) attributable to Class A Common Stockholders		(594,418)		(207,272)		(18,020)
Dilutive effect of warrants on net income to Class A Common Stockholders		—		—		(30,181)

Dilutive effect of Class B Common Stockholders		(504,485)		—		(86,334)
Net income (loss) attributable to Class A Common Stockholders - Diluted		$	(1,098,903)	$	(207,272)	$	(134,535)
Basic and Diluted Loss Per Share denominator:
Weighted average Common Stock outstanding - basic		2,754,116		2,191,669		1,705,072
Net income (loss) per share - basic		$	(215.83)	$	(94.57)	$	(10.57)
Diluted Loss Per Share:
Dilutive effect of warrants on weighted average Common Stock outstanding		—		—		2,249

Dilutive effect of Class B Common Stock on weighted average Common Stock outstanding		1,775,506		—		3,049,651
Weighted average Common Stock outstanding - diluted		4,529,622		2,191,669		4,756,972
Net income (loss) per share - diluted		$	(242.60)	$	(94.57)	$	(28.28)

Schedule of Diluted Net Income (Loss) Per Share

The table below presents the Company’s potentially dilutive securities:


						As of December 31, 2023

Public Warrants						229,999
Private Placement Warrants						105,333

Restricted Stock Units						156,771
Stock Options						77,289
Contingent Shares Issued in Connection with Acquisitions						27,210

Potential Common Stock Equivalents						596,602